Shares of Puma tumbled Wednesday, nearing a nine-year low, after the German sportswear group warned that geopolitical tensions and trade uncertainty would contribute to another year of weak growth.

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment. Puma Biotechnology ...

Our calculations are based on comprehensive, delayed quotes. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all ...

Puma is forecasting weak sales growth and lower earnings this year as the German sporting-goods company braces for more geopolitical tensions and economic hurdles, particularly trade disputes and ...